Drug delivery systems' role in preventing central line-associated bacteraemia: An international perspective

Alan Lyles, John Fanikos, George Whitelaw, K. B. Bamford, E. Bouza, Victor D. Rosenthal, Wing Hong Seto, Shmuel Shoham, C. Von Eiff

Research output: Contribution to journalArticle

Abstract

Study objectives: An International Roundtable of infectious disease experts reviewed regional differences in approaches to healthcare-associated bacteraemia reduction, assessed the drug delivery system's role, and made best practice recommendations. Results: Bloodstream infection (BSI) surveillance and clinical management practices vary greatly within and between nations, particularly between economically developed and low income countries. The solution is not to impose a single standard since actions that reduce BSIs and their optimal sequence also differ by a region's economic development level. Conclusion: Education improves BSI rates most where rates are catastrophic; however, reducing already low rates requires more than education. Consequently, technology's greatest impact will be when drug delivery systems are already quite improved. The participants made seven recommendations.

Original languageEnglish (US)
Pages (from-to)39-44
Number of pages6
JournalEJHP Practice
Volume15
Issue number5
StatePublished - 2009
Externally publishedYes

Fingerprint

Internationality
Drug Delivery Systems
Bacteremia
Education
Economic Development
Practice Management
Infection
Practice Guidelines
Communicable Diseases
Technology
Delivery of Health Care

Keywords

  • Bacteraemia
  • Bloodstream infection
  • Central line
  • Drug delivery system
  • International surveillance

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Lyles, A., Fanikos, J., Whitelaw, G., Bamford, K. B., Bouza, E., Rosenthal, V. D., ... Von Eiff, C. (2009). Drug delivery systems' role in preventing central line-associated bacteraemia: An international perspective. EJHP Practice, 15(5), 39-44.

Drug delivery systems' role in preventing central line-associated bacteraemia : An international perspective. / Lyles, Alan; Fanikos, John; Whitelaw, George; Bamford, K. B.; Bouza, E.; Rosenthal, Victor D.; Seto, Wing Hong; Shoham, Shmuel; Von Eiff, C.

In: EJHP Practice, Vol. 15, No. 5, 2009, p. 39-44.

Research output: Contribution to journalArticle

Lyles, A, Fanikos, J, Whitelaw, G, Bamford, KB, Bouza, E, Rosenthal, VD, Seto, WH, Shoham, S & Von Eiff, C 2009, 'Drug delivery systems' role in preventing central line-associated bacteraemia: An international perspective', EJHP Practice, vol. 15, no. 5, pp. 39-44.
Lyles A, Fanikos J, Whitelaw G, Bamford KB, Bouza E, Rosenthal VD et al. Drug delivery systems' role in preventing central line-associated bacteraemia: An international perspective. EJHP Practice. 2009;15(5):39-44.
Lyles, Alan ; Fanikos, John ; Whitelaw, George ; Bamford, K. B. ; Bouza, E. ; Rosenthal, Victor D. ; Seto, Wing Hong ; Shoham, Shmuel ; Von Eiff, C. / Drug delivery systems' role in preventing central line-associated bacteraemia : An international perspective. In: EJHP Practice. 2009 ; Vol. 15, No. 5. pp. 39-44.
@article{03111dc6973149f8adae5cae827a5e88,
title = "Drug delivery systems' role in preventing central line-associated bacteraemia: An international perspective",
abstract = "Study objectives: An International Roundtable of infectious disease experts reviewed regional differences in approaches to healthcare-associated bacteraemia reduction, assessed the drug delivery system's role, and made best practice recommendations. Results: Bloodstream infection (BSI) surveillance and clinical management practices vary greatly within and between nations, particularly between economically developed and low income countries. The solution is not to impose a single standard since actions that reduce BSIs and their optimal sequence also differ by a region's economic development level. Conclusion: Education improves BSI rates most where rates are catastrophic; however, reducing already low rates requires more than education. Consequently, technology's greatest impact will be when drug delivery systems are already quite improved. The participants made seven recommendations.",
keywords = "Bacteraemia, Bloodstream infection, Central line, Drug delivery system, International surveillance",
author = "Alan Lyles and John Fanikos and George Whitelaw and Bamford, {K. B.} and E. Bouza and Rosenthal, {Victor D.} and Seto, {Wing Hong} and Shmuel Shoham and {Von Eiff}, C.",
year = "2009",
language = "English (US)",
volume = "15",
pages = "39--44",
journal = "EJHP Practice",
issn = "1781-9989",
publisher = "Pharma Publishing and Media Europe",
number = "5",

}

TY - JOUR

T1 - Drug delivery systems' role in preventing central line-associated bacteraemia

T2 - An international perspective

AU - Lyles, Alan

AU - Fanikos, John

AU - Whitelaw, George

AU - Bamford, K. B.

AU - Bouza, E.

AU - Rosenthal, Victor D.

AU - Seto, Wing Hong

AU - Shoham, Shmuel

AU - Von Eiff, C.

PY - 2009

Y1 - 2009

N2 - Study objectives: An International Roundtable of infectious disease experts reviewed regional differences in approaches to healthcare-associated bacteraemia reduction, assessed the drug delivery system's role, and made best practice recommendations. Results: Bloodstream infection (BSI) surveillance and clinical management practices vary greatly within and between nations, particularly between economically developed and low income countries. The solution is not to impose a single standard since actions that reduce BSIs and their optimal sequence also differ by a region's economic development level. Conclusion: Education improves BSI rates most where rates are catastrophic; however, reducing already low rates requires more than education. Consequently, technology's greatest impact will be when drug delivery systems are already quite improved. The participants made seven recommendations.

AB - Study objectives: An International Roundtable of infectious disease experts reviewed regional differences in approaches to healthcare-associated bacteraemia reduction, assessed the drug delivery system's role, and made best practice recommendations. Results: Bloodstream infection (BSI) surveillance and clinical management practices vary greatly within and between nations, particularly between economically developed and low income countries. The solution is not to impose a single standard since actions that reduce BSIs and their optimal sequence also differ by a region's economic development level. Conclusion: Education improves BSI rates most where rates are catastrophic; however, reducing already low rates requires more than education. Consequently, technology's greatest impact will be when drug delivery systems are already quite improved. The participants made seven recommendations.

KW - Bacteraemia

KW - Bloodstream infection

KW - Central line

KW - Drug delivery system

KW - International surveillance

UR - http://www.scopus.com/inward/record.url?scp=70450178030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450178030&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:70450178030

VL - 15

SP - 39

EP - 44

JO - EJHP Practice

JF - EJHP Practice

SN - 1781-9989

IS - 5

ER -